MedTech Connect Capital

www.medtechvp.com

VCMatch tracks MedTech Connect Capital as an investor focused on Medtech, AI/ML, and Data Infrastructure companies, Pre-Seed and Seed rounds, and United States, San Francisco Bay Area, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A

Focus Areas

Medtech, AI/ML, Data Infrastructure

Geography

United States, San Francisco Bay Area, and global

Investment Thesis

MedTech Venture Partners focuses on investing in and actively supporting medical device entrepreneurs, leveraging deep industry operating experience to de‑risk and scale early‑stage device businesses. The firm emphasizes hands‑on support informed by extensive clinical and regulatory experience, transactional experience (buying and selling technologies, products, and companies), and a track record of device development: “Combined, our team has overseen the conception, development, and launch of over 30 medical devices and diagnostics products.” They also explicitly partner with academic/clinical ecosystems to accelerate early‑stage device innovation: “Together with our partners at UCSF we are building an exciting ecosystem around early stage medical devices.”

Is MedTech Connect Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

MedTech Connect Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Medtech, AI/ML, Data Infrastructure, and Hardware, especially across United States, San Francisco Bay Area, and global.

Focus statement

"A focus on device entrepreneurs." The firm states plainly: "At MedTech Venture Partners, we fund and support medical technology entrepreneurs," with emphasis on early‑stage medical devices and diagnostics (portfolio and pipeline items span neuromodulation, surgical devices, implants, neonatal devices, imaging/analytics, and drug delivery platforms).

Value Add

Device‑specific, operator and executive team: multiple partners are former CEOs and senior device executives (e.g., former CEOs of Gambro, HemoCue, Siemens roles) giving deep operating and commercialization experience.
Proven track record: "over 30 medical devices and diagnostics products" overseen from conception to launch.
Clinical and regulatory depth: explicit claim of "extensive clinical and regulatory experience globally" and multiple clinical advisors from UCSF and other institutions.
Academic/clinical partnership with UCSF: they are building an ecosystem together, providing access to clinical expertise and translation resources.
Strong advisor network spanning corporate development, legal, and VC (e.g., Brook Byers, Casey McGlynn, Chris Eso) to support fundraising, exits, and strategic partnerships.